Shareholders’ General Meeting 2020 in Camera
Shareholders’ General Meeting 2020 in Camera Visit the Shareholders’ Resources section to register to the live transmission to learn […]
Onxeo’s Joint General Meeting in camera on May 29, 2020: availability of preparatory documents and live webcast login information
Paris (France), May 7, 2020 – 7:30 a.m. CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO – FR0010095596), (“Onxeo”, […]
Ordinary General Meeting of May 22, 2019
Renewal of the terms of office of Danièle Guyot-Caparros, Jean-Pierre Bizzari and Jean-Pierre Kinet Appointment of Danièle Guyot-Caparros as Chairman […]
Ordinary General Meeting on April 26, 2019
Paris (France), April 5, 2019 – 10 pm CET – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), a biotechnology company […]
Annual General Meeting of May 16, 2018
Approval of all ordinary resolutions Renewal of the terms of office of Mr. Thomas Hofstaetter Notice of a new Extraordinary […]
Combined General Meeting on May 16, 2018
Paris, April 25, 2018 – 6:30 pm CEST – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO FR0010095596), a biotechnology company […]
Annual General Meeting of April 26, 2017
All ordinary resolutions approved Two new independent directors appointed Renewal of the terms of office of Mrs Judith Greciet, CEO, […]
Combined General Meeting on April 26, 2017
Paris (France), April 5, 2017 – 6 pm CET – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), a biotechnology company […]
Passing on Onxeo’s Extraordinary and Ordinary General Meeting
Paris (France), Copenhagen (Denmark) – Onxeo S.A. (Euronext Paris, Nasdaq Copenhagen: ONXEO), an innovative company specializing in the development of orphan […]
Onxeo Ordinary and Extraordinary General Meeting on April 6, 2016
Paris (France), Copenhagen (Denmark) – Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan […]
Onxeo’s Combined General Meeting of Shareholders 2015
Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, today announced […]
Annual General Shareholders’ Meeting 2015: Results and convening to a new Meeting
Onxeo S.A. (Euronext Paris, NASDAQ Copenhague : ONXEO), société innovante spécialisée dans le développement de médicaments orphelins en oncologie, informe ses […]
Combined Ordinary and Extraordinary General Meeting on April 15, 2015: Procedures for obtaining preparatory documents
Onxeo’s shareholders are invited to attend the Combined Ordinary and Extraordinary General Meeting to be held at 9:30am on April […]
BioAlliance Pharma Announces Shareholders’ Meeting and Approval of all resolutions
BioAlliance Pharma SA (Euronext Paris – BIO), an innovative Company specialized in the development of drugs in orphan oncology diseases, […]